Knuff & Co’s Novo Nordisk NVO Stock Holding History

Knuff & Co’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.6M	Buy	242,776 +7,547	+3%	+$324K	2.95%	10
2026 Q1	$8.64M	Buy	235,229 +63,479	+37%	+$3.01M	2.6%	12
2025 Q4	$8.74M	Sell	171,750 -83,274	-33%	-$4.26M	2.58%	10
2025 Q3	$14.2M	Buy	255,024 +127,105	+99%	+$7.44M	4.1%	5
2025 Q2	$8.83M	Buy	127,919 +44,053	+53%	+$3M	2.78%	9
2025 Q1	$5.82M	Buy	83,866 +68,792	+456%	+$5.68M	1.95%	17
2024 Q4	$1.3M	Buy	15,074 +7,953	+112%	+$860K	0.39%	47
2024 Q3	$848K	Buy	7,121 +3,954	+125%	+$527K	0.26%	61
2024 Q2	$452K	Buy	3,167 +3,102	+4,772%	+$411K	0.15%	76
2024 Q1	$8.35K	Buy	+65	New	+$7.74K	﹤0.01%	123

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Knuff & Co's NVO Position: Q2 2026 in Review

Knuff & Co increased its Novo Nordisk (NVO) stake by 3.2% in Q2 2026, buying an estimated $324K and bringing the position to 242,776 shares worth $11.6M. The position accounts for 2.95% of the portfolio, ranked #10.

Knuff & Co first reported a position in NVO in Q1 2024 and has held it in 10 quarters since. The position peaked at $14.2M in Q3 2025. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Knuff & Co held 242,776 shares of Novo Nordisk worth $11.6M as of Q2 2026.
Knuff & Co bought 7,547 Novo Nordisk shares in Q2 2026, an estimated $324K.
Novo Nordisk made up 2.95% of Knuff & Co's portfolio in Q2 2026, its #10 holding.
Knuff & Co first reported a position in Novo Nordisk in Q1 2024 and has held it in 10 quarters since.
Knuff & Co's Novo Nordisk position peaked at $14.2M in Q3 2025.
1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Knuff & Co's 13F filing for Q2 2026, filed 10 Aug 2026.